CVR Medical Corp (CRRVF)

[conix]

CRRVF INVESTMENT HIGHLIGHTS

*Strokes - leading cause of disability globally; 5th leading cause of death(US); Asymptomatic

*Game changing technology - 2 minute detection; Mobile Devices

*"Cost" of strokes expected to TRIPLE by 2030 from 2010 $71.6 Billion cost globally(2010)

*Carotid Stenotic Scan(CSS) - groundbreaking tool assessing arterial health in a way unavailable to patient/provider now

*Manufacturing Agreement signed with Canon Virginia Inc(subsidiary of Canon USA - also a Strategic Partner)

*Currently in Clinical Trials and submitted in January 2019 to FDA for US Market Approval